Epidemiology of Hormone Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer in the U.S., 2011─2022: A Retrospective Observational Study
Real-World Tumor BRCA Testing Patterns and PARP Inhibitor Use in HER2-Negative Metastatic Breast Cancer
Treatment Patterns of Gemcitabine-Based Chemotherapy in Patients with De Novo and Recurrent Advanced Biliary Tract Cancer
